Status and phase
Conditions
Treatments
About
The optimal regimen for adjuvant treatment has not been established in GC yet. We plan to compare TS-1, TS-1/oxaliplatin with or without RT in D2 resected gastric cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subjects presenting with any of the following will not be included in the study
Primary purpose
Allocation
Interventional model
Masking
547 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal